Pfizer Says CHMP Gives Positive Opinion For Anti-Smoking Pill Champix – Update
July 31st, 2006
Pfizer, Inc. revealed it has received a positive opinion from the Committee for Medical Products for Human Use or CHMP to authorize the marketing of Champix, which is the company’s new drug for the treatment of smoking cessation.